Key result
KCNE3 transmembrane domain drives KCNQ1 assembly and modulation while C-terminal KCNE1 mutations cluster in alpha-helices.
This basic science study elucidates the structural interactions between KCNQ1 and KCNE peptides, providing molecular insights into cardiac repolarization and Long QT syndrome.
Offers structural basis for KCNQ1-KCNE function; leaves open therapeutic targeting in Long QT syndrome.
KCNQ1 is a homotetrameric voltage-gated potassium channel expressed in cardiomyocytes and epithelial tissues. However, currents arising from KCNQ1 have never been physiologically observed. KCNQ1 is able to provide the diverse potassium conductances required by these distinct cell types through coassembly with and modulation by type I transmembrane β-subunits of the KCNE gene family. KCNQ1-KCNE K + channels play important physiological roles. In cardiac tissues the association of KCNQ1 with KCNE1 gives rise to I Ks , the slow delayed outwardly rectifying potassium current. I Ks is in part responsible for repolarizing heart muscle, and is therefore crucial in maintaining normal heart rhymicity. I Ks channels help terminate each action potential and provide cardiac repolarization reserve. As such, mutations in either subunit can lead to Romano-Ward Syndrome or Jervell and Lange-Nielsen Syndrome, two forms of Q-T prolongation. In epithelial cells, KCNQ1-KCNE1, KCNQ1-KCNE2 and KCNQ1-KCNE3 give rise to potassium currents required for potassium recycling and secretion. These functions arise because the biophysical properties of KCNQ1 are always dramatically altered by KCNE co-expression. We wanted to understand how KCNE peptides are able to modulate KCNQ1. In Chapter II, we produce partial truncations of KCNE3 and demonstrate the transmembrane domain is necessary and sufficient for both assembly with and modulation of KCNQ1. Comparing these results with published results obtained from chimeric KCNE peptides and partial deletion mutants of KCNE1, we propose a bipartite modulation residing in KCNE peptides. Transmembrane modulation is either active (KCNE3) or permissive (KCNE1). Active transmembrane KCNE modulation masks juxtamembranous C-terminal modulation of KCNQ1, while permissive modulation allows C-terminal modulation of KCNQ1 to express. We test our hypothesis, and demonstrate C-terminal Long QT point mutants in KCNE1 can be masked by active trasnsmembrane modulation. Having confirmed the importance the C-terminus of KCNE1, we continue with two projects designed to elucidate KCNE1 C-terminal structure. In Chapter III we conduct an alanine-perturbation scan within the C-terminus. C-terminal KCNE1 alanine point mutations result in changes in the free energy for the KCNQ1-KCNE1 channel complex. High-impact point mutants cluster in an arrangement consistent with an alphahelical secondary structure, kinked by a single proline residue. In Chapter IV, we use oxidant-mediated disulfide bond formation between non-native cysteine residues to demonstrate amino acid side chains residing within the C-terminal domain of KCNE1 are close and juxtaposed to amino acid side chains on the cytoplasmic face of the KCNQ1 pore domain. Many of the amino acids identified as high impact through alanine perturbation correspond with residues identified as able to form disulfide bonds with KCNQ1. Taken together, we demonstrate that the interaction between the C-terminus of KCNE1 and…
No takes yet. Share an insight, caveat, or question.
Steven D. Gage (2008) studied Long QT Syndrome (Romano-Ward Syndrome, Jervell and Lange-Nielsen Syndrome). KCNE peptide mutations and truncations was evaluated on KCNQ1-KCNE channel complex modulation and structure. The transmembrane domain of KCNE3 is necessary and sufficient for assembly with and modulation of KCNQ1, and C-terminal KCNE1 mutations cluster in an alpha-helical secondary structure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: